Villadiego Luque, F. J., García Swinburn, R., García González, D., Lebrón-Galán, R., Murcia-Belmonte, V., García Roldán, E., . . . Toledo Aral, J. J. (2023). Extracellular matrix protein anosmin‑1 overexpression alters dopaminergic phenotype in the CNS and the PNS with no pathogenic consequences in a MPTP model of Parkinson’s disease.
Citación estilo ChicagoVilladiego Luque, Francisco Javier, et al. Extracellular Matrix Protein Anosmin‑1 Overexpression Alters Dopaminergic Phenotype in the CNS and the PNS With No Pathogenic Consequences in a MPTP Model of Parkinson’s Disease. 2023.
Cita MLAVilladiego Luque, Francisco Javier, et al. Extracellular Matrix Protein Anosmin‑1 Overexpression Alters Dopaminergic Phenotype in the CNS and the PNS With No Pathogenic Consequences in a MPTP Model of Parkinson’s Disease. 2023.